Stock DNTH DIANTHUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Dianthus Therapeutics, Inc.

Equities

DNTH

US2528281080

Real-time Estimate Cboe BZX
Other stock markets
 12:16:26 2024-06-17 pm EDT 		5-day change 1st Jan Change
25.06 USD -3.63% Intraday chart for Dianthus Therapeutics, Inc. +29.16% +150.00%
Jun. 12 Dianthus Therapeutics Secures US FDA Approval to Launch Phase 2 Study of DNTH103 in Multifocal Motor Neuropathy MT
Jun. 12 Dianthus Therapeutics Gets FDA Clearance for DNTH103 Phase 2 Trial DJ
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
DIANTHUS THERAPEUTICS, INC. Stock Dianthus Therapeutics, Inc.
 763M - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
GENMAB A/S Stock Genmab A/S
 16.88B
  1. Stock Market
  2. Equities
  3. DNTH Stock
  4. Charts Dianthus Therapeutics, Inc.
  5. Sector Chart